Evommune (EVMN) EBIT (2024 - 2026)
Evommune (EVMN) reported EBIT of -$24.0 million for Q1 2026, down 59.35% year-over-year from -$58.9 million in Q1 2025, and up 19.39% on a QoQ basis from -$29.7 million in Q4 2025.
Evommune (EVMN) has 3 years of EBIT data on file, last reported at -$24.0 million in Q1 2026.
- Quarterly EBIT fell 59.35% year-over-year to -$24.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.0 million (changed N/A YoY) and the FY2025 annual result came in at -$81.1 million, down 15.79% from the prior year.
- EBIT improved to -$24.0 million in Q1 2026 per EVMN's latest filing, from -$29.7 million in the prior quarter.
- Across five years, EBIT topped out at -$13.3 million in Q3 2025 and bottomed at -$29.7 million in Q4 2025.
- The 3-year median for EBIT is -$19.0 million (2024), against an average of -$20.0 million.
- The widest annual swing landed in 2025, when EBIT gained 19.31%; it then slumped 59.35% in 2026.
- Tracing EVMN's EBIT over 3 years: stood at -$21.5 million in 2024, then sank by 38.51% to -$29.7 million in 2025, then increased by 19.39% to -$24.0 million in 2026.
- Per Business Quant, the three latest EVMN EBIT figures stand at -$24.0 million (Q1 2026), -$29.7 million (Q4 2025), and -$13.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Evommune | 782.16 Mn | 570.69 Mn | - | -23.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.95 Mn |
| Dec 31, 2025 | -29.72 Mn |
| Sep 30, 2025 | -13.33 Mn |
| Mar 31, 2025 | -15.03 Mn |
| Dec 31, 2024 | -21.45 Mn |
| Sep 30, 2024 | -16.52 Mn |